Net Profit Margin
since 2005
Paying user area
Try for free
Abiomed Inc. pages available for free this week:
- Cash Flow Statement
- Common-Size Balance Sheet: Assets
- Analysis of Liquidity Ratios
- Analysis of Solvency Ratios
- DuPont Analysis: Disaggregation of ROE, ROA, and Net Profit Margin
- Enterprise Value to EBITDA (EV/EBITDA)
- Enterprise Value to FCFF (EV/FCFF)
- Price to Book Value (P/BV) since 2005
- Analysis of Revenues
- Analysis of Debt
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Abiomed Inc. for $22.49.
This is a one-time payment. There is no automatic renewal.
We accept:
Calculation
Abiomed Inc., net profit margin, long-term trends, calculation
| Net profit margin | = | 100 | × | Net income (loss)1 | ÷ | Revenue1 | |
|---|---|---|---|---|---|---|---|
| Mar 31, 2022 | = | 100 | × | ÷ | |||
| Mar 31, 2021 | = | 100 | × | ÷ | |||
| Mar 31, 2020 | = | 100 | × | ÷ | |||
| Mar 31, 2019 | = | 100 | × | ÷ | |||
| Mar 31, 2018 | = | 100 | × | ÷ | |||
| Mar 31, 2017 | = | 100 | × | ÷ | |||
| Mar 31, 2016 | = | 100 | × | ÷ | |||
| Mar 31, 2015 | = | 100 | × | ÷ | |||
| Mar 31, 2014 | = | 100 | × | ÷ | |||
| Mar 31, 2013 | = | 100 | × | ÷ | |||
| Mar 31, 2012 | = | 100 | × | ÷ | |||
| Mar 31, 2011 | = | 100 | × | ÷ | |||
| Mar 31, 2010 | = | 100 | × | ÷ | |||
| Mar 31, 2009 | = | 100 | × | ÷ | |||
| Mar 31, 2008 | = | 100 | × | ÷ | |||
| Mar 31, 2007 | = | 100 | × | ÷ | |||
| Mar 31, 2006 | = | 100 | × | ÷ | |||
| Mar 31, 2005 | = | 100 | × | ÷ |
Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31), 10-K (reporting date: 2016-03-31), 10-K (reporting date: 2015-03-31), 10-K (reporting date: 2014-03-31), 10-K (reporting date: 2013-03-31), 10-K (reporting date: 2012-03-31), 10-K (reporting date: 2011-03-31), 10-K (reporting date: 2010-03-31), 10-K (reporting date: 2009-03-31), 10-K (reporting date: 2008-03-31), 10-K (reporting date: 2007-03-31), 10-K (reporting date: 2006-03-31), 10-K (reporting date: 2005-03-31).
1 US$ in thousands
- Revenue Trends
- The revenue demonstrates a consistent upward trajectory across the entire period under review. Starting from approximately $38.2 million in 2005, the figure steadily increased each year, reaching over $1 billion by 2022. This indicates robust top-line growth, reflecting expanded sales or service delivery over time.
- Net Income (Loss) Trends
- Net income exhibits significant volatility in the early years, with losses recorded from 2005 through 2010. Losses peaked particularly in 2006 and 2008, with negative values near $29.4 million and $40.9 million, respectively. From 2011 onwards, net income turned positive, showing considerable improvements especially from 2014 to 2019. The income peaked sharply in 2019 at approximately $259 million before declining in subsequent years but remained positive through 2022.
- Net Profit Margin Trends
- The net profit margin aligns with the net income trend, reflecting substantial negative margins in the initial years, reaching nearly -69% in 2008. From 2012, margins turned positive, indicating a move towards profitability. Margin expansion continued, with notable spikes, including a peak of approximately 49.36% in 2014 and a high margin around 33.66% in 2019. After 2019, margins decreased but remained positive, signaling ongoing profitability despite some contraction.
- Insights
- The data points to a company that initially struggled with profitability but managed to establish a strong growth pattern in revenue while transitioning to consistent profitability after 2010. The peak in net income and profit margin around 2019 suggests a period of exceptional operational performance or possibly non-recurring gains. The subsequent decline in net income and margin after 2019 could warrant further investigation, though overall financial health appears improved relative to the initial years. The persistent revenue growth alongside improving profitability metrics indicates successful scaling of business operations and enhanced efficiency or product mix over the long term.
Comparison to Competitors
Abiomed Inc., net profit margin, long-term trends, comparison to competitors
| Abiomed Inc. | Abbott Laboratories | Elevance Health Inc. | Intuitive Surgical Inc. | Medtronic PLC | UnitedHealth Group Inc. | |
|---|---|---|---|---|---|---|
| Mar 31, 2022 | ||||||
| Mar 31, 2021 | ||||||
| Mar 31, 2020 | ||||||
| Mar 31, 2019 | ||||||
| Mar 31, 2018 | ||||||
| Mar 31, 2017 | ||||||
| Mar 31, 2016 | ||||||
| Mar 31, 2015 | ||||||
| Mar 31, 2014 | ||||||
| Mar 31, 2013 | ||||||
| Mar 31, 2012 | ||||||
| Mar 31, 2011 | ||||||
| Mar 31, 2010 | ||||||
| Mar 31, 2009 | ||||||
| Mar 31, 2008 | ||||||
| Mar 31, 2007 | ||||||
| Mar 31, 2006 | ||||||
| Mar 31, 2005 |
Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31), 10-K (reporting date: 2016-03-31), 10-K (reporting date: 2015-03-31), 10-K (reporting date: 2014-03-31), 10-K (reporting date: 2013-03-31), 10-K (reporting date: 2012-03-31), 10-K (reporting date: 2011-03-31), 10-K (reporting date: 2010-03-31), 10-K (reporting date: 2009-03-31), 10-K (reporting date: 2008-03-31), 10-K (reporting date: 2007-03-31), 10-K (reporting date: 2006-03-31), 10-K (reporting date: 2005-03-31).
Comparison to Sector (Health Care Equipment & Services)
Abiomed Inc., net profit margin, long-term trends, comparison to sector (health care equipment & services)
| Abiomed Inc. | Health Care Equipment & Services | |
|---|---|---|
| Mar 31, 2022 | ||
| Mar 31, 2021 | ||
| Mar 31, 2020 | ||
| Mar 31, 2019 | ||
| Mar 31, 2018 | ||
| Mar 31, 2017 | ||
| Mar 31, 2016 | ||
| Mar 31, 2015 | ||
| Mar 31, 2014 | ||
| Mar 31, 2013 | ||
| Mar 31, 2012 | ||
| Mar 31, 2011 | ||
| Mar 31, 2010 | ||
| Mar 31, 2009 | ||
| Mar 31, 2008 | ||
| Mar 31, 2007 | ||
| Mar 31, 2006 | ||
| Mar 31, 2005 |
Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31), 10-K (reporting date: 2016-03-31), 10-K (reporting date: 2015-03-31), 10-K (reporting date: 2014-03-31), 10-K (reporting date: 2013-03-31), 10-K (reporting date: 2012-03-31), 10-K (reporting date: 2011-03-31), 10-K (reporting date: 2010-03-31), 10-K (reporting date: 2009-03-31), 10-K (reporting date: 2008-03-31), 10-K (reporting date: 2007-03-31), 10-K (reporting date: 2006-03-31), 10-K (reporting date: 2005-03-31).
Comparison to Industry (Health Care)
Abiomed Inc., net profit margin, long-term trends, comparison to industry (health care)
| Abiomed Inc. | Health Care | |
|---|---|---|
| Mar 31, 2022 | ||
| Mar 31, 2021 | ||
| Mar 31, 2020 | ||
| Mar 31, 2019 | ||
| Mar 31, 2018 | ||
| Mar 31, 2017 | ||
| Mar 31, 2016 | ||
| Mar 31, 2015 | ||
| Mar 31, 2014 | ||
| Mar 31, 2013 | ||
| Mar 31, 2012 | ||
| Mar 31, 2011 | ||
| Mar 31, 2010 | ||
| Mar 31, 2009 | ||
| Mar 31, 2008 | ||
| Mar 31, 2007 | ||
| Mar 31, 2006 | ||
| Mar 31, 2005 |
Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31), 10-K (reporting date: 2016-03-31), 10-K (reporting date: 2015-03-31), 10-K (reporting date: 2014-03-31), 10-K (reporting date: 2013-03-31), 10-K (reporting date: 2012-03-31), 10-K (reporting date: 2011-03-31), 10-K (reporting date: 2010-03-31), 10-K (reporting date: 2009-03-31), 10-K (reporting date: 2008-03-31), 10-K (reporting date: 2007-03-31), 10-K (reporting date: 2006-03-31), 10-K (reporting date: 2005-03-31).